In Depth 8 Apr 2024
A wave of biotech layoffs: will the trend continue throughout 2024?
Thousands of jobs have been at risk over the past year due to mass layoffs by biotech companies across the globe.
investment
- Latest Posts
In Depth 21 Mar 2024
Biotech in France: What’s holding back progress and how to move forward?
Explore the latest insights from France Biotech’s ‘Panorama France HealthTech’ report, uncovering key insights of the French biotech sector.
In Depth 18 Mar 2024
Will the US biotech funding surge trigger a renaissance in the global biotech industry?
After a couple of challenging years in biotech investment, the US leads the march for recovery. Delve into the specifics driving this uptick.
In Depth 6 Mar 2024
The biggest private biotech investments in February 2024
The companies BioAge Labs, Latigo Biotherapeutics, and Neurona Therapeutics bagged the biggest private biotech investments in February 2024.
Best in Biotech 5 Mar 2024
Fourteen biotech companies with market caps exceeding $100 billion
Discover the biotech leaders with a market capitalization exceeding $100 billion, driving innovation and shaping tomorrow’s breakthroughs.
In Depth 9 Feb 2024
Biotech job market 2024: what to expect?
The past year saw pipeline cuts and downsizing plans strike the biotech industry. Does the biotech job market seem to be looking up this year?
ADVERTISEMENT
ADVERTISEMENT
In Depth 7 Feb 2024
The biggest private biotech investments in January 2024
Jixing Pharmaceuticals, COUR Pharmaceuticals, and OnCusp Therapeutics bagged the biggest private biotech investments in January 2024.
In Depth 10 Jan 2024
The biggest private biotech investments in December 2023
The companies Tome Biosciences, Bicara Therapeutics, and Seismic Therapeutic bagged the biggest biotech investments in December 2023. Around the world, food, immunology, oncology, central nervous system (CNS), and biofermentation players attracted the biggest funding rounds overall. Although December is generally a quiet time for biotech fundraising, there were still some big rounds raised in the […]
Opinion 18 Dec 2023
What to expect from biotech clinical trials in the coming year
As cancer research has seen an increase in funding lately, here are some of the key clinical trends that you can expect in 2024.
In Depth 7 Dec 2023
The biggest private biotech investments in November 2023
The companies Cambrian Innovation, Terremoto Biosciences, and VectorY Therapeutics bagged the biggest biotech investments in November 2023. Around the world, oncology and central nervous system players attracted the biggest funding rounds. As we edge closer to Christmas, biotech fundraising appears to be drying up a bit; there was a significant decrease in funding rounds in […]
News and Trends 20 Nov 2023
M&As: what’s up with the ADC buying spree?
Antibody drug conjugates (ADCs) have been much sought-after through investments of late, with big pharma eyeing these drugs developed by various biotechs, to eventually nab them. With yet another ADC being bought by Bristol Myers Squibb, and AbbVie’s proposed $10 billion deal to seize ImmunoGen’s oncology pipeline, are these drugs the golden ticket to targeted […]
News and Trends 17 Nov 2023
With $700 million Q3 rise, U.K. biotech spearheads European recovery
The U.K.’s biotechnology landscape has witnessed an impressive surge in funding, clocking a robust £563 million ($700 million) in venture capital and public financings in the third quarter of 2023, according to Biotech Finance. This achievement marks a staggering 48% increase from the previous quarter and sets a formidable pace that is already on track […]
ADVERTISEMENT